Frontier Biotechnologies, Inc. engages in the research and development, production, and sale of medicines. Its offers include anti-human immunodeficiency virus treatment and pain treatment. The company was founded by Dong Xie, Chang Jin Wang and Rong Jian Lu on January 15, 2013 and is headquartered in Nanjing, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company